Die

 

  LEBER

 

STIFTUNG

 

 

 
 
 

3. Hepatolgie Symposium 2018: Anticoagulation treatment for portal vein thrombosis in patients with cirrhosis: DOACs – are we still far from using them?

3. Hepatolgie Symposium 2018: Anticoagulation treatment for portal vein thrombosis in patients with cirrhosis: DOACs – are we still far from using them?

Prof. Dr. med. Andrea De Gottardi, Universitätsklinik Insel Spital Bern, Schweiz

Prof. Dr. med. Andrea De Gottardi, Leitender Arzt am SwissLiver Center und Professor an der Universität Bern, Schweiz spricht während des
3. Hepatologie Symposiums am 21. Juni 2018 über das Thema: Anticoagulation treatment for portal vein thrombosis in patients with cirrhosis.